• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Neomend

edit

Neomend, Inc., a biomedical device company, engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally invasive/laparoscopic procedures. Neomend, Inc. was founded in 1999 and is based in Irvine, California.

Recent Milestones

edit

• 
  Neomend was acquired by C. R. Bard. (10/23/12)
  Posted 10/25/12 at 6:25pm via dowjones.com
• 
  Neomend received $20M in Series D funding. (8/3/11)
  Posted 8/3/11 at 4:11am via dowjones.com
• 
  Neomend received $30M in Series D funding. (1/27/10)
  Posted 1/27/10 at 9:51pm via finsmes.com
• 
  Neomend added David Renzi as President & CEO.
  Posted 1/27/10 at 9:51pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/28/10

Sources

1. C.R. Bard Acquires Neomend (pevc.dowjones.com) [edit]
2. Neomend Closes $30M Funding Round (finsmes.com) [edit]
3. Surgical Sealant Maker NeoMend Adds $20M To Series D Round (fis.dowjones.com) [edit]